Skip to main content

Fifth Third Bancorp

SEC CIK
0000035527
Latest filing
Aug 5, 2026

APVO holding history

Aptevo Therapeutics Inc. in every 13F filed by Fifth Third Bancorp, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

APVO overviewAll 13F holders of APVOFull Q2 2026 holdings

Shares (Q3 2024)
0
Sold out in Q3 2024
Value
$0
% of portfolio
0.0%
Quarters held
14
Since Q1 2021
Holdings of APVO by Fifth Third Bancorp, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q3 20240$00.0%−6−100.0%Sold outHolders
Q2 20246$2<0.1%00.0%UnchangedHolders
Q1 20246$28<0.1%−285−97.9%ReducedHolders
Q4 2023291$53<0.1%00.0%UnchangedHolders
Q3 2023291$96<0.1%00.0%UnchangedHolders
Q2 2023291$425<0.1%00.0%UnchangedHolders
Q1 2023291$592<0.1%00.0%UnchangedHolders
Q4 2022291$675<0.1%00.0%UnchangedHolders
Q3 2022291$1.00K<0.1%00.0%UnchangedHolders
Q2 2022291$1.00K<0.1%00.0%UnchangedHolders
Q1 2022291$2.00K<0.1%00.0%UnchangedHolders
Q4 2021291$2.00K<0.1%00.0%UnchangedHolders
Q3 2021291$4.00K<0.1%00.0%UnchangedHolders
Q2 2021291$7.00K<0.1%00.0%UnchangedHolders
Q1 2021291$9.00K<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.